BRCA1 and cancer: Their analysis indicates that they target Gallus gallus tumor suppressor genes, including TP53, which encodes the p53 protein, a key factor in anti-cancer therapy [42], and BRCA1, which encodes the breast cancer susceptibility protein type 1.